N. ANTHONY COLES

Insider Reports History

Location
Parsippany, NJ
Signature
By: Richard Gluckselig as attorney-in-fact For: N. Anthony Coles
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by N. ANTHONY COLES:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. Director Common Stock 1,714 $1,322,985 $771.87 02 Jan 2026 Direct
Cerevel Therapeutics Holdings, Inc. Director Common Stock 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director Restricted Stock Units 0 $0 $41.18 01 Aug 2024 Direct
REGENERON PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 1,962 02 Jan 2026 Direct
Cerevel Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 01 Aug 2024 Direct

Insider Reports Filed by N. ANTHONY COLES

Symbol Company Period Transactions Value $ Form Type Role Filing Time
REGN REGENERON PHARMACEUTICALS, INC. 02 Jan 2026 2 $0 4 Director 06 Jan 2026, 16:11
REGN REGENERON PHARMACEUTICALS, INC. 02 Jan 2025 2 $0 4 Director 06 Jan 2025, 16:12
CERE Cerevel Therapeutics Holdings, Inc. 01 Aug 2024 4 $0 4 Director 05 Aug 2024, 16:20
CERE Cerevel Therapeutics Holdings, Inc. 01 Jul 2024 3 -$942,035 4 Director 03 Jul 2024, 16:05
CERE Cerevel Therapeutics Holdings, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:34
CERE Cerevel Therapeutics Holdings, Inc. 03 Jun 2024 3 -$1,855,520 4 Director 05 Jun 2024, 16:05
CERE Cerevel Therapeutics Holdings, Inc. 10 May 2024 3 -$1,930,125 4 Director 14 May 2024, 17:16
CERE Cerevel Therapeutics Holdings, Inc. 01 Apr 2024 3 -$1,941,640 4 Director 03 Apr 2024, 16:15
CERE Cerevel Therapeutics Holdings, Inc. 04 Mar 2024 3 -$1,875,550 4 Director 06 Mar 2024, 16:15
CERE Cerevel Therapeutics Holdings, Inc. 29 Feb 2024 3 -$1,882,890 4 Director 04 Mar 2024, 17:49
CERE Cerevel Therapeutics Holdings, Inc. 06 Feb 2024 3 -$104,110 4 Director 08 Feb 2024, 19:14
CERE Cerevel Therapeutics Holdings, Inc. 02 Jan 2024 3 -$1,936,815 4 Director 04 Jan 2024, 16:15
REGN REGENERON PHARMACEUTICALS, INC. 02 Jan 2024 2 $0 4 Director 04 Jan 2024, 16:11
CERE Cerevel Therapeutics Holdings, Inc. 14 Nov 2023 3 -$493,571 4 Director 16 Nov 2023, 16:15
CERE Cerevel Therapeutics Holdings, Inc. 07 Nov 2023 6 -$584,955 4 Director 09 Nov 2023, 17:03
CERE Cerevel Therapeutics Holdings, Inc. 02 Nov 2023 6 -$2,183,697 4 Director 06 Nov 2023, 17:12
CERE Cerevel Therapeutics Holdings, Inc. 07 Sep 2023 3 -$1,028,415 4 Director 08 Sep 2023, 16:35
CERE Cerevel Therapeutics Holdings, Inc. 11 Jul 2023 3 -$1,326,340 4 Director 13 Jul 2023, 17:41
CERE Cerevel Therapeutics Holdings, Inc. 01 Jun 2023 3 -$1,455,070 4 CEO and Chairperson, Director 05 Jun 2023, 20:12
CERE Cerevel Therapeutics Holdings, Inc. 04 May 2023 5 -$1,398,434 4 CEO and Chairperson, Director 08 May 2023, 16:24
CERE Cerevel Therapeutics Holdings, Inc. 11 Apr 2023 3 -$1,078,130 4 CEO and Chairperson, Director 13 Apr 2023, 16:48
CERE Cerevel Therapeutics Holdings, Inc. 02 Mar 2023 6 -$1,180,947 4 CEO and Chairperson, Director 06 Mar 2023, 15:15
CERE Cerevel Therapeutics Holdings, Inc. 06 Feb 2023 6 -$1,481,401 4 CEO and Chairperson, Director 08 Feb 2023, 19:27
CERE Cerevel Therapeutics Holdings, Inc. 05 Jan 2023 4 -$1,321,871 4 CEO and Chairperson, Director 06 Jan 2023, 16:04
REGN REGENERON PHARMACEUTICALS, INC. 03 Jan 2023 2 $0 4 Director 05 Jan 2023, 15:15
REGN REGENERON PHARMACEUTICALS, INC. 28 Dec 2022 12 -$1,565,412 4 Director 30 Dec 2022, 15:10
CERE Cerevel Therapeutics Holdings, Inc. 09 Dec 2022 4 -$1,158,300 4 CEO and Chairperson, Director 13 Dec 2022, 15:44
REGN REGENERON PHARMACEUTICALS, INC. 06 Sep 2022 13 -$1,253,229 4 Director 08 Sep 2022, 16:06
CERE Cerevel Therapeutics Holdings, Inc. 09 Feb 2022 1 $0 4 CEO and Chairperson, Director 11 Feb 2022, 17:45
REGN REGENERON PHARMACEUTICALS, INC. 03 Jan 2022 2 $0 4 Director 05 Jan 2022, 15:23
REGN REGENERON PHARMACEUTICALS, INC. 15 Sep 2021 17 -$3,500,677 4 Director 17 Sep 2021, 16:01
REGN REGENERON PHARMACEUTICALS, INC. 17 Aug 2021 6 -$1,827,180 4 Director 19 Aug 2021, 16:04
REGN REGENERON PHARMACEUTICALS, INC. 13 Aug 2021 3 -$559,060 4 Director 16 Aug 2021, 16:04